首页 > 产品目录 > 生命科学 > 核苷 > α-L-Talofuranuronamide, 5-O-[3-O-(11-amino-1-oxoundecyl)-4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-deoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-decanoate (ACI)
[CAS No.1194506-21-2] A1255091 α-L-Talofuranuronamide, 5-O-[3-O-(11-amino-1-oxoundecyl)-4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-deoxy-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-decanoate (ACI) 97%
目录号:
Cas No.:
分子式:
分子量:
MDL No:
EINECS:
订单/询价/技术支持
电话: 0086-571-89925085
下单 & 咨询: sales@amadischem.com
技术支持: tech@amadischem.com
*本公司所有化学品仅供实验室和生产用途
质量控制 [1194506-21-2]

NMR

CNMR

HPLC

LC-MS

相关文件 [1194506-21-2]
基础信息 [1194506-21-2]
同义词:
外观:
熔点:
沸点:
闪点:
存储要求:
Pubchem ID:
Smiles:
Inchi:
InchiKey:
安全信息 [1194506-21-2]
警示图:
警示词:
UN No.:
危险类别:
包装等级:
危险申明:
防范说明:
相关文献 [1194506-21-2]
抱歉,暂无相关文献
相似产品 [1194506-21-2]
α-L-Talofuranuronamide, 1-deoxy-5-O-[2,3-di-O-benzoyl-4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-benzoate (9CI)
Reason:核苷
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-(1-ethylpentyl)-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
Reason:核苷
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-3-O-[(dodecyloxy)carbonyl]-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
Reason:核苷
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-3-O-[(heptyloxy)carbonyl]-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
Reason:核苷
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-3-O-[(dodecyloxy)carbonyl]-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
Reason:核苷
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-3-O-[(heptyloxy)carbonyl]-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl- (9CI)
Reason:核苷
α-L-Talofuranuronamide, 1-deoxy-5-O-[(6S)-4,5-di-O-acetyl-3-deoxy-D-erythro-hex-2-enodialdo-6,2-pyranosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-acetate (ACI)
Reason:核苷
α-L-Talofuranuronamide, 1-deoxy-5-O-[2,3-di-O-acetyl-4-deoxy-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-acetate (ACI)
Reason:核苷
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S)-hexahydro-2-oxo-1H-azepin-3-yl]-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-heptadecanoate (9CI)
Reason:核苷
α-L-Talofuranuronamide, 1-deoxy-5-O-[4-deoxy-N-[(3S,7R)-hexahydro-7-methyl-2-oxo-1H-azepin-3-yl]-2,3-O-(1-methylethylidene)-β-L-erythro-hex-4-enopyranuronamidosyl]-1-(3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinyl)-3-O-methyl-, 2-(2,2-dimethyldodecanoate) (9CI)
Reason:核苷
产品详情 [1194506-21-2]
抱歉,暂无产品详情
浏览记录
有竞争力的价格
高效物流
技术支持
货物充足